Reaction
Oral Surgery reporting signals
As of the last recalculation, Oral Surgery appears in 2,293 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES (PRR 21.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 20 | 21.3 | 21.3 |
| Alendronate Sodium | 173 | 16.8 | 16.8 |
| Upadacitinib | 127 | 14.9 | 14.9 |
| Ibrutinib | 114 | 13.4 | 13.4 |
| Armodafinil | 26 | 11.3 | 11.3 |
| Zoledronic Acid | 43 | 9.9 | 9.9 |
| Sodium Oxybate | 69 | 9.8 | 9.8 |
| Risankizumab-Rzaa | 82 | 9.4 | 9.4 |
| Thalidomide | 34 | 8.5 | 8.5 |
| Bicalutamide | 12 | 7.2 | 7.2 |
| Thyroid, Porcine | 8 | 6.8 | 6.8 |
| Modafinil | 23 | 6.5 | 6.5 |
| Avapritinib | 8 | 6.0 | 6.0 |
| Naltrexone | 19 | 5.6 | 5.6 |
| Denosumab | 118 | 5.5 | 5.5 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate | 21 | 5.4 | 5.4 |
| Niraparib | 12 | 4.9 | 4.9 |
| Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate | 22 | 4.9 | 4.9 |
| Tofacitinib | 94 | 4.8 | 4.8 |
| Romosozumab-Aqqg | 7 | 4.7 | 4.7 |
| Linaclotide | 13 | 4.4 | 4.4 |
| Selexipag | 12 | 4.2 | 4.2 |
| Abatacept | 58 | 3.9 | 3.9 |
| Glecaprevir And Pibrentasvir | 4 | 3.3 | 3.3 |
| Cenegermin-Bkbj | 4 | 3.0 | 3.0 |
| Acalabrutinib | 4 | 3.0 | 3.0 |
| Droxidopa | 7 | 3.0 | 3.0 |
| Etanercept | 177 | 2.8 | 2.8 |
| Sarilumab | 8 | 2.8 | 2.8 |
| Esketamine Hydrochloride | 5 | 2.5 | 2.5 |
| Apalutamide | 3 | 2.3 | 2.3 |
| Palbociclib | 24 | 2.3 | 2.3 |
| Bimekizumab | 5 | 2.1 | 2.1 |
| Voxelotor | 5 | 2.0 | 2.0 |
| Valbenazine | 3 | 1.1 | 1.1 |
| Pimavanserin Tartrate | 6 | 1.0 | 1.0 |